HIMACS (4299) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Jul, 2026Executive summary
Net sales increased by 4.1% year-over-year to ¥18,066 million for the fiscal year ended March 31, 2025.
Operating profit rose 5.1% to ¥1,807 million, and profit attributable to owners of parent grew 9.2% to ¥1,293 million year-over-year.
Comprehensive income reached ¥1,316 million, up 7.6% from the previous year.
Financial highlights
Gross profit increased to ¥3,643 million from ¥3,537 million year-over-year.
Ordinary profit was ¥1,821 million, up 5.3% year-over-year.
Basic earnings per share rose to ¥111.59 from ¥101.89 year-over-year.
Equity-to-asset ratio improved to 81.6% from 80.5% year-over-year.
Cash and cash equivalents at year-end were ¥8,319 million, up from ¥8,096 million.
Outlook and guidance
For the fiscal year ending March 31, 2026, net sales are forecast to rise 10.7% to ¥20,000 million.
Operating profit is projected at ¥1,820 million (up 0.7%), and profit attributable to owners of parent is expected to decrease 3.7% to ¥1,245 million.
Basic earnings per share forecasted at ¥107.40 for the next fiscal year.
Latest events from HIMACS
- Stable sales and profit growth with positive full-year outlook and robust equity position.4299
Q1 202520 Jul 2026 - Profits and sales rose year-over-year, with strong outlook and higher dividend forecast.4299
Q2 202520 Jul 2026 - Profits and sales rose year-over-year, with a higher full-year outlook and dividend forecast.4299
Q3 202520 Jul 2026 - Sales rose, but profits fell sharply; full-year outlook sees higher revenue but lower net income.4299
Q1 202620 Jul 2026 - Sales rose modestly, but profits declined; full-year outlook expects higher sales and stable margins.4299
Q2 202620 Jul 2026 - Revenue grew slightly, but profits and cash reserves declined due to higher expenses and share buybacks.4299
Q3 202620 Jul 2026 - Sales rose modestly, but profits fell and next year's earnings are forecast to decline further.4299
Q4 202620 Jul 2026